Across TCGA cell cohorts, SLC22A12 RNA expression is significantly associated with the mutation status of many other genes, with 101 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible SLC22A12-associated genes across cancer lineages are LRP2, ASPM, and BCHE. Each is linked with SLC22A12 in more than 2 cancer types. Because this analysis shows association rather than direction, both SLC22A12-to-partner and partner-to-SLC22A12 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SLC22A12→partner) and Y-score (partner→SLC22A12) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LUNG_SCLC	LRP2 →	+1.616	+0.003	.002	.005	3	3
URINARY_TRACT	ASPM →	+4.087	+0.005	.009	<.001	3	2
BLOOD_Myeloma	BCHE →	+4.807	+0.023	.006	<.001	3	2
KIDNEY	DNAH3 →	+3.491	+0.009	.006	<.001	3	2
BLOOD_Leukemia	TCF3 →	+3.316	+0.002	.003	<.001	3	2
BLOOD_Leukemia	OR51I1 →	+4.539	+0.004	.007	<.001	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 101 associations by consensus.

Exploration

SLC22A12 survival (RNA) · tumor vs normal (RNA) · all SLC22A12 data types